A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial

Author： Lloyd A.   Holman A.   Evers T.  

Publisher： Informa Healthcare

E-ISSN： 0300-7995|24|5|1279-1284

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.5, 2008-05, pp. : 1279-1284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study*

By Frei C. R.   Jaso T. C.   Mortensen E. M.   Restrepo M. I.   Raut M. K.   Oramasionwu C. U.   Ruiz A. D.   Makos B. R.   Ruiz J. L.   Attridge R. T.   Mody S. H.   Fisher A.   Schein J. R.  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 859-868

Informa Healthcare

Access to resources Recommend Favorite

A Prospective, Randomized, Multicenter Comparative Study of Clinafloxacin Versus a Ceftriaxone-based Regimen in the Treatment of Hospitalized Patients with Community-acquired Pneumonia

By Petermann W.   Alegre-Martin J.   Odenholt I.   Phillips M. J.   Willcox P. A.   Tack K.   Trostmann U.   Welling L.  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 11, 2001-11 ,pp. : 832-837

Informa Healthcare

Access to resources Recommend Favorite

A Comparative Study of Levofloxacin and Ceftriaxone in the Treatment of Hospitalized Patients with Pneumonia

By Norrby S. Ragnar   Petermann Wolfgang   Willcox Paul Anthony   Vetter Norbert   Salewski Erich  

Scandinavian Journal of Infectious Diseases, Vol. 30, Iss. 4, 1998-09 ,pp. : 397-404

Informa Healthcare

Access to resources Recommend Favorite

Community‐Acquired Pneumonia in Older Patients

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 44, Iss. 5, 1996-05 ,pp. : 539-544

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia

By File Thomas M.   Milkovich Gary   Tennenberg Alan M.   Xiang Jim X.   Khashab Mohammed M.   Zadeikis Neringa  

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1473-1481

Informa Healthcare

Access to resources Recommend Favorite